Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho Kwong Li

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos Medicine|May 21, 2015
An unsupported preference for intravenous antibioticsHo Kwong Li, Ambrose Agweyu, Mike English, et al.
The Lancet. Infectious Diseases|September 28, 2019
The OVIVA trialPhilip A Bejon, Ho Kwong Li, Ines Rombach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Cerebral sinus thrombosis and leptomeningeal carcinomatosis in a patient with ovarian cancerHo Kwong Li, Victoria Harding, Ruth Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2025
Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and WalesHo Kwong Li, Nina Zhu, Olivia Waddell, et al.
Wellcome Open Research|January 14, 2020
Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trialNicola McMeekin, Claudia Geue, Andrew Briggs, et al.
Microbial Genomics|December 20, 2023
Characterization of the RofA regulon in the pandemic M1<sub>global</sub> and emergent M1<sub>UK</sub> lineages of <i>Streptococcus pyogenes</i>Xiangyun Zhi, Ana Vieira, Kristin K Huse, et al.
Emerging Infectious Diseases|April 5, 2023
Emerging Invasive Group A Streptococcus M1<sub>UK</sub> Lineage Detected by Allele-Specific PCR, England, 2020<sup>1</sup>Xiangyun Zhi, Ho Kwong Li, Hanqi Li, et al.
Microbial Genomics|April 24, 2023
Characterization of emergent toxigenic M1<sub>UK</sub> <i>Streptococcus pyogenes</i> and associated sublineagesHo Kwong Li, Xiangyun Zhi, Ana Vieira, et al.
The Lancet. Infectious Diseases|September 15, 2019
Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyNicola N Lynskey, Elita Jauneikaite, Ho Kwong Li, et al.
Med (New York, N.Y.)|February 7, 2022
Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, Elena Chekmeneva, Heather Jackson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos Medicine|May 21, 2015
An unsupported preference for intravenous antibioticsHo Kwong Li, Ambrose Agweyu, Mike English, et al.
The Lancet. Infectious Diseases|September 28, 2019
The OVIVA trialPhilip A Bejon, Ho Kwong Li, Ines Rombach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2011
Cerebral sinus thrombosis and leptomeningeal carcinomatosis in a patient with ovarian cancerHo Kwong Li, Victoria Harding, Ruth Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2025
Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and WalesHo Kwong Li, Nina Zhu, Olivia Waddell, et al.
Wellcome Open Research|January 14, 2020
Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection: evidence from a non-inferiority trialNicola McMeekin, Claudia Geue, Andrew Briggs, et al.
Microbial Genomics|December 20, 2023
Characterization of the RofA regulon in the pandemic M1<sub>global</sub> and emergent M1<sub>UK</sub> lineages of <i>Streptococcus pyogenes</i>Xiangyun Zhi, Ana Vieira, Kristin K Huse, et al.
Emerging Infectious Diseases|April 5, 2023
Emerging Invasive Group A Streptococcus M1<sub>UK</sub> Lineage Detected by Allele-Specific PCR, England, 2020<sup>1</sup>Xiangyun Zhi, Ho Kwong Li, Hanqi Li, et al.
Microbial Genomics|April 24, 2023
Characterization of emergent toxigenic M1<sub>UK</sub> <i>Streptococcus pyogenes</i> and associated sublineagesHo Kwong Li, Xiangyun Zhi, Ana Vieira, et al.
The Lancet. Infectious Diseases|September 15, 2019
Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyNicola N Lynskey, Elita Jauneikaite, Ho Kwong Li, et al.
Med (New York, N.Y.)|February 7, 2022
Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, Elena Chekmeneva, Heather Jackson, et al.
Pageof 2